AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Vaginal Misoprostol Superior to Oral for Induction.
RENO, NEV. -- Vaginally administered misoprostol was more effective than the oral drug for cervical ripening and labor induction in a double-blind, randomized, controlled trial.
A group of 126 women undergoing labor induction was given 50 [micro]g of misoprostol orally every 3 hours or vaginally every 6 hours. Delivery of their babies occurred within 12 hours in 36% of women in the intravaginal misoprostol group and in 13% of those in the oral group, Dr. Stephanie Fisher reported at the annual meeting of the Society for Maternal-Fetal Medicine.
Within 24 hours, delivery was complete in 73% of the vaginal drug group and in 52% of the oral drug group. These differences were statistically significant, said Dr. Fisher of Queen's University, Kingston, Ont.
A favorable cervix was obtained in 17 hours with the oral drug and 12.4 hours with the vaginal preparation. And when misoprostol was delivered vaginally, the time from induction to delivery was 19.2 hours, ...
- EURAND AWARD HONOURS ACHIEVEMENTS IN ORAL DRUG DELIVERY RESEARCH.
- News wire article from: AsiaPulse News August 10, 2007 700+ words
...research scientists in the field of applied oral drug delivery. The Awards recognized exceptional innovation in Oral Drug Delivery and exceptional contributions...the category of "Novel Approached in Oral Drug Delivery" and also selected an individual...
- Eurand Award Honors Achievements in Oral Drug Delivery Research.
- Press release article from: PR Newswire August 9, 2007 700+ words
...research scientists in the field of applied oral drug delivery. The Awards recognized exceptional innovation in Oral Drug Delivery and exceptional contributions...the category of "Novel Approached in Oral Drug Delivery" and also selected an individual...
- Second oral drug delivery research deal signed.
- Newspaper article from: Biotech Business Week June 7, 2004 700+ words
...announced that it has commenced a second oral drug delivery research collaboration with...combining Access' proprietary vitamin B12 oral drug delivery technology with the collaborator's proprietary formulations to provide oral drug delivery options for these formulations...
- Access Pharmaceuticals, Inc. Announces Second Oral Drug Delivery Research...
- Press release article from: PR Newswire May 13, 2004 700+ words
...announced that it has commenced a second oral drug delivery research collaboration with...combining Access' proprietary vitamin B12 oral drug delivery technology with the collaborator's proprietary formulations to provide oral drug delivery options for these formulations...
- Oral Drug Delivery Strategies Summit to Highlight New Technologies.
- Press release article from: PR Newswire May 14, 2003 700+ words
...YORK, May 14 /PRNewswire/ -- The Oral Drug Delivery Strategies Summit 2003, presented...focuses on the advancing science of oral drug delivery systems. Theses systems include...current and exciting developments in the oral drug delivery arena from big pharma, biotech...
- Access Pharmaceuticals, Inc. Announces Oral Drug Delivery Research...
- Press release article from: PR Newswire September 11, 2003 700+ words
...entered into a research collaboration in oral drug delivery with the Celltech Group plc...goal of the collaboration is to develop oral drug delivery options for Celltech's monoclonal...using Access' proprietary vitamin B12 oral drug delivery technology. In preclinical...
- Access Pharmaceuticals Inc announces oral drug delivery research collaboration.
- News wire article from: Asia Africa Intelligence Wire September 11, 2003 700+ words
...entered into a research collaboration in oral drug delivery with the Celltech Group plc...goal of the collaboration is to develop oral drug delivery options for Celltech's monoclonal...using API's proprietary vitamin B12 oral drug delivery technology. In pre-clinical...
- Access Pharmaceuticals, Inc. Announces Third Oral Drug Delivery Research...
- Press release article from: PR Newswire May 12, 2005 700+ words
...announced that it has commenced a third oral drug delivery research collaboration. This...combining Access' proprietary vitamin B12 oral drug delivery technology with the potential...Hunter-Fleming Ltd. The vitamin B12 oral drug delivery technology utilizes the body...
- Access Pharmaceuticals Inc announces second oral drug delivery research...
- News wire article from: Asia Africa Intelligence Wire May 13, 2004 700+ words
...Pharmaceuticals Inc has commenced second oral drug delivery research collaboration with...Pharmaceuticals' proprietary vitamin B12 oral drug delivery technology with the collaborator's proprietary formulations to provide oral drug delivery options for these formulations...
- Spherics to Receive ''Novel Approaches in Oral Drug Delivery'' Award at the...
- Press release article from: Business Wire June 15, 2005 700+ words
...receive an award for "Novel Approaches to Oral Drug Delivery" for research to be presented...clinical proof-of-concept for Spherics' oral drug delivery technology platform. The Controlled...developing improved products with our novel oral drug delivery platform," said Ze'ev Shaked...
Source: HighBeam Research, Vaginal Misoprostol Superior to Oral for Induction.